利用活动性结核药物监测和管理中的经验来监测抗逆转录病毒药物的毒性。
Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity.
机构信息
FHI 360 Asia Pacific Regional Office, Bangkok, Thailand.
FHI 360 Papua New Guinea Office, Port Moresby, Papua New Guinea.
出版信息
Glob Health Sci Pract. 2022 Apr 29;10(2). doi: 10.9745/GHSP-D-21-00595. Print 2022 Apr 28.
Abstract
Systems established for active drug safety monitoring and management of drug-resistant TB should be leveraged to ensure comprehensive surveillance for active toxicity monitoring during scale-up of newer antiretroviral regimens.
摘要
应利用建立的主动药物安全性监测系统和耐多药结核病药物管理系统，确保在扩大新型抗逆转录病毒方案时，全面监测药物的毒性。
Zotero 插件